Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVASTIGMINE Cause Gamma-glutamyltransferase increased? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Gamma-glutamyltransferase increased have been filed in association with RIVASTIGMINE (Exelon). This represents 0.1% of all adverse event reports for RIVASTIGMINE.

6
Reports of Gamma-glutamyltransferase increased with RIVASTIGMINE
0.1%
of all RIVASTIGMINE reports
1
Deaths
3
Hospitalizations

How Dangerous Is Gamma-glutamyltransferase increased From RIVASTIGMINE?

Of the 6 reports, 1 (16.7%) resulted in death, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Gamma-glutamyltransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVASTIGMINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does RIVASTIGMINE Cause?

Death (1,229) Fall (587) Malaise (514) Drug ineffective (510) Product adhesion issue (478) Vomiting (432) Dementia alzheimer's type (428) Memory impairment (385) Nausea (383) Pneumonia (378)

What Other Drugs Cause Gamma-glutamyltransferase increased?

FINGOLIMOD (635) ACETAMINOPHEN (442) METHOTREXATE (421) ATORVASTATIN (376) RIBOCICLIB (375) LETROZOLE (323) DEXAMETHASONE (292) CYCLOPHOSPHAMIDE (277) CARBOPLATIN (262) NIVOLUMAB (261)

Which RIVASTIGMINE Alternatives Have Lower Gamma-glutamyltransferase increased Risk?

RIVASTIGMINE vs RIVOTRIL RIVASTIGMINE vs RIZATRIPTAN RIVASTIGMINE vs ROACTEMRA RIVASTIGMINE vs ROCURONIUM RIVASTIGMINE vs ROFECOXIB

Related Pages

RIVASTIGMINE Full Profile All Gamma-glutamyltransferase increased Reports All Drugs Causing Gamma-glutamyltransferase increased RIVASTIGMINE Demographics